{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:27:45Z","timestamp":1791167265296,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.mvr.2005.01.002","type":"journal-article","created":{"date-parts":[[2005,2,27]],"date-time":"2005-02-27T00:43:45Z","timestamp":1109465025000},"page":"56-63","source":"Crossref","is-referenced-by-count":234,"title":["Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro"],"prefix":"10.1016","volume":"69","author":[{"given":"Keith","family":"Dredge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Horsfall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Shirley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Stirling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus G.","family":"Dalgleish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Blake","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2005.01.002_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrc1323","article-title":"The evolution of thalidomide and its IMiD derivatives as anticancer agents","volume":"4","author":"Bartlett","year":"2004","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.mvr.2005.01.002_bib2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.bjc.6601579","article-title":"Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers","volume":"90","author":"Bartlett","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.mvr.2005.01.002_bib3","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood-2002-09-2907","article-title":"Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma","volume":"101","author":"Bisping","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2005.01.002_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mvr.2005.01.002_bib5","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/01.CIR.103.16.2102","article-title":"Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt\/endothelial nitric oxide synthase pathway","volume":"103","author":"Chavakis","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.mvr.2005.01.002_bib6","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mvr.2005.01.002_bib7","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival: a play in three Akts","volume":"13","author":"Datta","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.mvr.2005.01.002_bib8","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.bjc.6600607","article-title":"Novel thalidomide analogs display anti-angiogenic activity independently of immunomodulatory effects","volume":"87","author":"Dredge","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mvr.2005.01.002_bib9","first-page":"182","article-title":"Tumor angiogenesis: therapeutic implications","volume":"181","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2005.01.002_bib10","doi-asserted-by":"crossref","first-page":"16349","DOI":"10.1074\/jbc.274.23.16349","article-title":"Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner","volume":"274","author":"Fujio","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2005.01.002_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1006\/exer.1997.0292","article-title":"Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization","volume":"64","author":"Kenyon","year":"1997","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mvr.2005.01.002_bib12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.RES.86.8.892","article-title":"Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine\/threonine kinase Akt","volume":"86","author":"Morales-Ruiz","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2005.01.002_bib13","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1021\/jm9603328","article-title":"Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity","volume":"39","author":"Muller","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mvr.2005.01.002_bib14","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0960-894X(99)00250-4","article-title":"Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production","volume":"9","author":"Muller","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.mvr.2005.01.002_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/mvre.1994.1041","article-title":"Basic fibroblast growth factor and de novo mammalian angiogenesis","volume":"48","author":"Norrby","year":"1994","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2005.01.002_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/mvre.1996.0017","article-title":"Vascular endothelial growth factor and de novo mammalian angiogenesis","volume":"51","author":"Norrby","year":"1996","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2005.01.002_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000179145","article-title":"Basic-fibroblast-growth-factor-mediated de novo angiogenesis is effectively suppressed by low-molecular-weight than by high-molecular-weight heparin","volume":"16","author":"Norrby","year":"1996","journal-title":"Int. J. Microcirc."},{"issue":"1","key":"10.1016\/j.mvr.2005.01.002_bib18","first-page":"136","article-title":"Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer","volume":"57","author":"O'Brien","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.mvr.2005.01.002_bib19","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood-2002-03-0996","article-title":"Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2005.01.002_bib20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.RES.0000022200.71892.9F","article-title":"Role of Akt signalling in vascular homeostasis and angiogenesis","volume":"90","author":"Shiojima","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2005.01.002_bib21","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumour activity of thalidomide in refractory multiple myeloma","volume":"341","author":"Singhal","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2005.01.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1998.1","article-title":"United Kingdom Coordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia, second edition","volume":"77","author":"Workman","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mvr.2005.01.002_bib23","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-04-0343","article-title":"Akt\/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286205000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286205000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T12:22:11Z","timestamp":1548678131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286205000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":23,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0026286205000038"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2005.01.002","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}